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N-Methylation of lysyl residues is widely observed on histone proteins. Using
isolated enzymes, we report mechanistic and structural studies on histone
lysine demethylase (KDM)-catalysed demethylation of Ne-methylated lysine
26 on histone 1 isotype 4 (H1.4). The results reveal that methylated H1.4K26
is a substrate for all members of the KDM4 subfamily and that KDM4A-cat-
alysed demethylation of H1.4K26me3 peptide is similarly efficient to that of
H3K9me3. Crystallographic studies of an H1.4K26me3:KDM4A complex
reveal a conserved binding geometry to that of H3K9me3. In the light of the
high activity of the KDM4s on this mark, our results suggest JmjC KDM-
catalysed demethylation of H1.4K26 may be as prevalent as demethylation
on the H3 tail and warrants further investigation in cells.
Keywords: 2-oxoglutarate oxygenases; demethylases; epigenetics; histones;
JmjC demethylases; lysine N-methylation
Widespread N-methylation of both arginyl and lysyl
residues occurs on the tails of core histones (histones
H2A, H2B, H3 and H4), where it has roles in regulat-
ing gene expression [1]. Lysyl residues can undergo
successive methylations on the Ne-nitrogen to give
three methylation states (mono-Ne-methyllysine, di-Ne-
methyllysine and tri-Ne-methyllysine respectively), as
catalysed by S-adenosylmethionine-dependent methyl-
transferases (KMTs) [2,3]. In many cases, KMTs catal-
yse methylation at multiple sites to give different
methylation states, on both histones and non-histone
proteins [1,4]. Enzyme-catalysed demethylation of
methylated lysyl residues also occurs at many sites on
histones H3 and H4 [1]. Thus, at least at certain sites,
lysyl methylation is dynamically regulated by the inter-
play between the two enzyme-catalysed processes.
Demethylation is catalysed by two families of his-
tone lysine demethylases (KDMs) [5]. Members of the
larger family of KDMs, JmjC KDMs, catalyse methyl
group oxidation coupled to oxygen-dependent oxida-
tive decarboxylation of 2-oxoglutarate (2OG), forming
succinate and carbon dioxide (Fig. 1A) [5]. The avail-
able evidence implies that the resultant hemiaminal is
normally unstable, fragmenting to give the demethy-
lated lysyl residue and formaldehyde [6]. Dysregulation
of JmjC KDM family members is implicated in many
diseases, including developmental disorders and many
cancers. The JmjC KDMs are thus the focus of drug
development programmes [7], although their physio-
logical roles are, in many cases, incompletely defined.
There is emerging evidence that certain KDMs have
multiple substrates including non-histone proteins and
potentially methylated arginyl residues [8,9], suggesting
the possibility for in vivo pleiotropy in KDM catalysis.
Though less well studied, lysyl methylation has been
observed on histones other than H3 and H4. Histone 1
Abbreviations
2OG, 2-oxoglutarate; FDH, formaldehyde dehydrogenase; HP1, heterochromatin protein 1; KDM, histone lysine demethylase; KMT, S-adeno-
sylmethionine-dependent methyltransferase; NOG, N-oxalylglycine.
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isotype 4 (H1.4), as opposed to the core histones H2A,
H2B, H3 and H4, is one of multiple ‘linker’ histones
that bind to nucleosomal DNA, but which do not form
part of the histone octamer [10]. Linker histones have
been traditionally viewed as playing important struc-
tural roles in stabilising higher order chromatin struc-
ture [11]. More recent evidence suggests that histone 1
isotypes and their post-translational modifications also
have additional functional roles within the cell, includ-
ing in transcriptional regulation [11,12]. To date, a
number of sites of histone H1.4 lysyl Ne-methylation
have been identified (Fig 1B), with H1.4K26 being the
most abundantly methylated site on H1.4 [13]. The
methylation status of H1.4K26 is reported to vary
dynamically during the cell cycle [14], and to undergo
KDM4-catalysed demethylation, as supported by
in vitro studies on mouse KDM enzymes [15]. The
methylation status of the H1.4K26 residue is com-
monly associated with repressed genes, and is known
to regulate binding of the family of heterochromatin
protein 1 (HP1) proteins and related chromodomains,
such as CDYL2 [16,17]. Loss of H1.4K26 (by substitu-
tion with a histone H1.4 variant bearing an alanine
residue at this position, H1.4K26A) results in a reduc-
tion of cell proliferation, deregulation of gene expres-
sion and a reduction of stabilisation of H1.4 in
heterochromatic regions [14]. Methylation of H1.4K26
also enhances phosphorylation of H1.4K27 by the Aur-
ora B kinase, which in turn hinders recruitment of HP1
to H1.4K26me2 [17,18]. H1.4K26 is also reported to be
acetylated by an unknown acetyltransferase, and to be
deacetylated by SIRT1 [19]. Thus, emerging, and
incompletely characterised, results indicate that com-
plex regulatory loops exist for H1.4, in addition to
those established with the core histones.
All human KDM4 enzymes catalyse demethylation
of H3K9 methylation, with KDM4A-C additionally
catalysing H3K36 demethylation [20–23]. Some KDM4
subfamily members have also been demonstrated to
catalyse in vitro demethylation of Ne-methylated H3K27
and arginine residues in the H3 and H4 tails [8,24]. With
respect to their activity on H1.4, it is currently unclear
(a) how the demethylation efficiency at H1.4K26 com-
pares to other KDM4 substrates (H3K9 and H3K36),
(b) how the H1.4K26 substrate binds within KDM4
active sites, and also (c) whether JmjC KDMs other
than the KDM4s can catalyse demethylation at H1.4K26.
To address these questions, we report studies investi-
gating human JmjC KDM-catalysed demethylation of
H1.4K26 methylation. Our findings reveal that
demethylation of methylated lysyl residues in H1.4K26
peptide fragments is catalysed by all members of the
human KDM4 subfamily of JmjC KDMs (KDM4A-
E), supporting previously reported cell-based studies
(predominantly with mouse enzymes) [15]. Unexpect-
edly, we also observed low level H1.4K26me2
demethylation activity by KDM7A and KDM7B
(PHF8), in the context of fragment peptides, though at
levels that may not be biologically relevant. While
demethylation of H1.4K26me2/1-containing peptides is
relatively inefficient for KDM7A and KDM7B, kinetic
analyses indicate that H1.4K26me3 is a comparably
efficient substrate for KDM4A as H3K9me3 (at least
in the context of fragment peptides) and is a better
substrate than H3K36me3. This assignment is sup-
ported by crystallographic studies indicating that the
H1.4K26me3 peptide binds to the KDM4 active site in
a similar manner to the H3K9me3 peptide. Overall,
H1.4K26me3 appears to be a good substrate for
KDM4A, and indeed other KDM4 enzymes, which is
Fig. 1. Demethylation by the JmjC KDMs.
(A) Outline mechanism of histone lysine
demethylation as catalysed by the JmjC
KDMs. (B) Sequence alignment of the first
15 residues of histone H3 with the
sequence of histone H1.4. The H3K9
position known to be methylated is
marked with a green circle. Other
positions known to be methylated on H1.4
are marked with yellow circles [12,13,45].
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supportive of its assignment as a KDM4 substrate in
mouse and human cells [15].
Materials and methods
Protein production
The catalytic domains of the JmjC KDMs used in this
work were recombinantly expressed as reported either in
Escherichia coli (KDM2A1–557 [25], KDM4A1–359 [26],
KDM4B1–359, KDM4C1–359, KDM4D1–359, KDM4E1–337
[27], KDM6B1141–1590 [28], KDM7B1–447 [29], KDM7A38–480
[28]) or Sf9 cells (KDM3A515–1317 [28], KDM5C1–765 [28]) as
N-terminally His6-tagged proteins. Proteins were purified by
Ni-affinity chromatography followed by size exclusion chro-
matography as previously described.
Peptide synthesis
Peptides were produced as C-terminal amides using a
Liberty Blue automated microwave peptide synthesiser
(CEM Corporation, Matthews, NC, USA), using standard
fluorenylmethyloxycarbonyl-mediated solid-phase chemistry
and NovaPEG rink amide resin (Merck, Kenilworth, NJ,
USA). Following synthesis, peptides were cleaved from the
resin by incubation with trifluoroacetic acid/water/triiso-
propylsilane/dimethoxybenzene (92.5 : 2.5 : 2.5 : 2.5) for
3 h followed by precipitation with ice-cold diethyl ether.
For kinetic experiments, lyophilised peptides were purified
by reverse-phase high-performance liquid chromatography
using a Vydac C18 column (Solvent A: 0.1% trifluoroacetic
acid in H2O, Solvent B: 0.1% trifluoroacetic acid in ace-
tonitrile). Sequences are given in Table S1.
MALDI-TOF MS activity assays
Recombinant proteins (1 lM) were incubated with peptides
(10 lM, sequences are given in Table S1) in 50 mM HEPES,
pH 7.5 with addition of Fe(II) ammonium sulfate (10 lM),
sodium ascorbate (100 lM) and 2-oxoglutaric acid
(200 lM). Reactions with KDM3A and KDM7A also con-
tained 1 mM tris(2-carboxyethyl)phosphine hydrochloride.
No enzyme reactions were included as negative controls.
Reactions were incubated for 1 h at 37 °C before being
quenched with 1 : 1 (v/v) methanol. Analysis was carried
out by MALDI-TOF MS (Bruker, Billerica, MA, USA),
with demethylation observed as mass shifts of 14 Da.
NMR activity assays
The NMR analyses employed a Bruker Avance III 700 MHz
spectrometer with an inverse TCI cryoprobe optimised for
1H observation and were carried out as previously described
[6]. Samples (KDM4A (10 lM), 2OG (400 lM), H1.4(18–32)
K26me3 peptide (400 lM), Fe(II) ammonium sulfate
(100 lM) and ascorbate (1 mM) in 50 mM ammonium for-
mate, pH 7.5, 500 mM NaCl in 10% v/v D2O) were prepared
in a microcentrifuge tube (total volume = 75 lL), before
being transferred to an NMR tube. The samples were then
analysed over time using automated routines; each time-
point corresponded to one experiment accumulating 16 tran-
sients (89 s total acquisition time per experiment). The sol-
vent resonance was depleted by excitation sculpting using a
180° sinc pulse (duration = 2 ms) [30].
Kinetic analyses
Kinetic parameters for KDM4 enzymes were determined by use
of an FDH (formaldehyde dehydrogenase)/NAD+-coupled)
assay for quantification of the formaldehyde reaction bypro-
duct, as previously described [27]. Assays were carried out in
50 mM HEPES, pH 7.5, 0.01% Tween-20, with addition of Fe
(II) ammonium sulfate (10 lM), sodium ascorbate (100 lM), 2-
oxoglutarate (200 lM), NAD+ (500 lM), KDM4 enzymes
(1 lM for specific activities, 500 nM for Michaelis–Menten
kinetics) and FDH enzyme (0.001 UlL1, Sigma-Aldrich, St
Louis, MO, USA) in a 30-lL volume in black 384-well plates.
Specific activities were measured using a 100-lM peptide. For
Michaelis–Menten experiments, peptide concentrations were
varied. Reactions were monitored using a PHERAstar FS plate
reader (BMGLabtech, Ortenberg, Germany) with 355 nm exci-
tation and 460 nm emission. Kinetic parameters were calculated
from the reaction rate during the initial linear phase of
formaldehyde production, which were used to calculate speci-
fic activities or fitted to Michaelis–Menten equations using
GRAPHPAD PRISM (GraphPad Software, La Jolla, CA, USA).
X-ray crystallography
Co-crystals of KDM4A1–359.Ni(II).H1.4(18–32)K26me3.
NOG were obtained in sitting drops grown at 4 °C with a
ratio of 1 : 2 sample to well solution [0.1 M MIB buffer (malo-
nic acid/imidazole/boric acid, pH 6.0, 25% w/v PEG 1500)]
[26]. Drops contained 10 mgmL1 KDM4A, 5 mM H1.4(18–
32)K26me3, 5 mM NOG and 4 mM NiCl2. Crystals were cry-
oprotected with 25% glycerol then flash-frozen in liquid N2.
Data were collected using a single crystal at 100 K at the Dia-
mond I04-1 MX beam line and were processed with HKL2000
[31]. The structure was solved by molecular replacement using
PHASER [32] (search model: PDB ID 2OX0) and was refined
by alternative cycles of CNS [33] and PHENIX[34], with itera-
tive rebuilding of the refined model using COOT [35]. All resi-
dues were in the allowed regions of the Ramachandran plot as
calculated by PROCHECK [36]. Data collection and refine-
ment statistics are given in Table S2. The crystal structure has
been deposited under PDB accession code 6H8P.
Results
The propensity of human JmjC KDMs to catalyse
demethylation at H1.4K26 was investigated using
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recombinant forms of the catalytic domains of repre-
sentatives of each human JmjC KDM subfamily
(KDM2-7) and fragment peptides (Table S1) [37].
Three peptides with identical sequences, corresponding
to residues 18–32 of histone H1.4 (H2N-TPVKKKA
RKSAGAAK-CONH2), but containing either a N
e-tri-,
di- or monomethyllysine at K26 were synthesised
(Fig. 1B and Table S1). Activity assays monitoring
JmjC KDM-catalysed demethylation of the peptides
were then carried out; samples were prepared contain-
ing each peptide, 2-oxoglutarate (2OG), ferrous iron,
ascorbate and individual representatives from each
JmjC KDM subfamily (KDM2A [38], KDM3A [21],
KDM4E [22], KDM5C [39,40], KDM6B [41],
KDM7A [42]). After incubation for 1 h at 37 °C,
matrix-assisted laser desorption ionisation mass spec-
trometry (MALDI-TOF MS) analysis revealed clear
demethylation of all three H1.4 peptides containing
Ne-lysine methylation at K26 in samples containing
KDM4E, consistent with previous in vitro and in cell
studies with closely related subfamily member,
KDM4D (Fig. 2A, Table 1 and Fig. S2) [15,43]. While
no evidence for demethylation was observed in sam-
ples of any of the H1.4 peptides with KDM2A,
KDM3A, KDM5C or KDM6B (Table 1, Figs S3–S6),
low levels of demethylation (<10%) of the mono- and
dimethylated H1.4K26 peptides were also observed in
samples containing KDM7A (Table 1, Fig. S7).
Given the activity observed with KDM4E and
KDM7A, we decided to investigate the intra-subfam-
ily conservation of this demethylation activity. The
demethylation activity of the other subfamily mem-
bers (KDM4A-D and KDM7B) was therefore
screened. For all KDM4 subfamily members, we
observed H1.4K26 demethylation activity similar to
that already observed with KDM4E (Table 1, Figs
S8–S11); however, no H1.4K26 demethylation activity
was observed with KDM7B at this enzyme concentra-
tion (Fig. S12). Note that as with H3K9, demethyla-
tion of the monomethylated H1.4K26 peptide was
only observed with KDM4E, under the stated condi-
tions [24].
Fig. 2. H1.4K26 N-terminal demethylation is catalysed by JmjC KDMs. (A) Demethylation of an H1.4(18–32)K26me3 peptide by KDM4E.
The red spectrum shows reactions containing enzyme; the black spectrum is a no enzyme control. (B) Comparison of activity of KDM7A
and KDM7B on H1.4K26 and H3K9 methylated peptides. Time course experiments containing the stated enzyme (5 lM) and peptides
(10 lM) were carried out at 37 °C, with samples removed and quenched at 8 time-points. Samples were analysed by MALDI-TOF MS. (C)
Graphs showing the degree of succinate production and peptide demethylation of H1.4(18–32)K26me3 catalysed by KDM4A as quantified
by 1H NMR (700 MHz). (D) Comparison of specific activity of KDM4 enzymes (1 lM) with H3(1–15)K9me3 and H1.4(18–32)K26me3
(100 lM). All data show the mean and standard deviation of technical triplicates.
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Ne-Trimethylated H3K4 binds to the plant home-
obox domain of KDM7B, targeting the Ne-dimethylly-
sine at H3K9 to the catalytic domain, and thus
promoting demethylation [29,44]. To test whether simi-
lar targeting may occur with H1.4, promoting activity
at H1.4K26, an H1.4 peptide was synthesised contain-
ing di-Ne-methyllysine at K26 and tri-Ne-methyllysine
at K21 (i.e. at the equivalent position in the sequence
to K4 in the H3 peptide, Fig. 1B, Table S1).
Monomethylation at H1.4K21 has previously been
observed by proteomic mass spectrometry [45]. With
the aim of enhancing activity, the enzyme concentra-
tion was increased from 1 lM to 5 lM, and time course
analyses were conducted with both KDM7A and
KDM7B, both with the new peptide (H1.4(18–32)
K21me3K26me2) and the H1.4 peptides methylated
only at K26 (Fig. 2B). At this increased enzyme con-
centration, clear evidence for demethylation of
H1.4K26me2 was observed with KDM7B in addition
to KDM7A (Fig. S12E), but no significant difference
was observed between the peptide with and without
methylation at H1.4K21 (Fig. 2B). Thus, it appears
unlikely that Ne-trimethylation at H1.4K21 promotes
demethylation at H1.4K26 by KDM7B. These time
courses, and similar ones with KDM7A, confirmed
that the H1.4K26 peptides were significantly
poorer substrates for the KDM7 subfamily than the
H3K9 peptides (the weak demethylation efficiency
observed for KDM7A/B precluded further kinetic
analyses).
Studies then focused on determining the proficiency
of H1.4K26 demethylation by the KDM4 enzymes.
Specific activities of each enzyme with H1.4K26me3
were compared to those with H3K9me3, and more
detailed studies were carried out with a representative
KDM4 enzyme, KDM4A. 1H NMR time course anal-
yses with KDM4A and the trimethylated H1.4K26me3
peptide confirmed time-dependent demethylation of
the Kme3 residue (Figs 2C, S13). The 1H NMR exper-
iments also revealed concomitant turnover of 2OG
into succinate (emergence of a singlet 1H resonance at
dH 2.28 ppm, Fig. S13) that is consistent with the pro-
posed demethylation mechanism [5].
Kinetic analyses were then undertaken using a
fluorescence-based formaldehyde dehydrogenase (FDH)-
coupled demethylation assay, which monitors the
formation of NADH during FDH-catalysed oxidation
of formaldehyde [27]. Initially, specific activities for
each KDM4 enzyme with either H1.4K26me3 or
H3K9me3 (each at 100 lM) were determined for com-
parison (Figs 2D, S14). These results revealed that in
all cases demethylation of the two different marks was
roughly comparable.
Michaelis–Menten kinetics were then conducted with
KDM4A. Samples containing KDM4A, 2OG, ascor-
bate, H1.4K26me3 peptide, NAD+ and FDH were
analysed over time and kinetic parameters were deter-
mined by recording the initial reaction rates of NADH
production (corresponding to enzymatic production of
formaldehyde) at varying peptide concentration. Simi-
lar experiments were carried out with H3K9me3 and
H3K36me3 substrate peptides and the obtained values
compared (Table 2). The experiments revealed that the
H1.4K26me3 and H3K9me3 peptides are similarly effi-
cient substrates of KDM4A, giving similar KM
(32.3  6.4 lM and 25.5  4.9 lM respectively) and kcat
(0.32  0.049 s1 and 0.31  0.045 s1 respectively) val-
ues. Demethylation of the H3K36me3 peptide was the
least efficient, with higher KM (66.8  5.4 lM) and lower
kcat (0.12  0.004 s1) values than with the other two
peptides.
Crystallographic analyses were undertaken to inves-
tigate the binding mode of trimethylated H1.4K26 in
Table 1. Summary of activity results for recombinant human JmjC
KDMs on methylated H1.4 peptides. Indicates that clear
demethylation activity was observed; Indicates that low level
demethylation activity was observed (<10% conversion after 1 h);
Indicates no activity under the stated conditions (1 lM KDM,
10 lM peptide); *Indicates demethylation activity was only
observed with 5 lM KDM.
Enzyme
H1.4(18–32)
K26me1
H1.4(18–32)
K26me2
H1.4(18–32)
K26me3
KDM2A
KDM3A
KDM4A
KDM4B
KDM4C
KDM4D
KDM4E
KDM5C
KDM6B
KDM7A
KDM7B * *
Table 2. Kinetic parameters for demethylation of H1.4 peptides by
recombinant human KDM4A (1 lM) measured using a formaldehyde
dehydrogenase-coupled demethylation assay [27]. Data show the
mean and standard deviation of three independent replicates. See
Materials and methods for complete assay conditions.
KM/lM kcat/s
1 kcat/KM
H3(1–15)K9me3 25.5  4.9 0.31  0.045 0.0124
H1.4(18–32)K26me3 32.3  6.4 0.32  0.049 0.0098
H3(29–43)K36me3 66.8  5.4 0.12  0.004 0.0019
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the KDM4A active site. An X-ray crystal structure of
a KDM4A:Ni(II):N-oxalylglycine:H1.4K26me3 peptide
complex was solved to a resolution of 1.98 A (Note:
Ni(II) was used for crystallisation in place of the cat-
alytically relevant Fe(II) due to its oxidative stability;
N-oxalylglycine (NOG) is a 2OG mimetic inhibitor)
[46]. Density was observed for H1.4 residues 24–29.
Refinement revealed the H1.4K26me3 peptide bound
in a cleft along the surface of KDM4A with the
methylated K26 residue protruding towards the active
site-bound metal centre (Figs 3A, S1), positioning the
carbon of the methyl group ~4 A from the active site
metal, apparently productively poised for enzymatic
hydroxylation and subsequent demethylation.
Comparison of the H1.4K26me3 complex structure
with those for a KDM4A:Ni(II):NOG:H3K9me3 pep-
tide complex (PDB: 2OQ6 [26], Fig. 3B) and a
KDM4A:Ni(II):NOG:H3K36me3 peptide complex
(PDB: 2P5B [47], Fig. 3C) reveals that all three
peptides bind with the side chain of the trimethyllysine
residue in the same orientation. All three peptides have
the same N- to C- directionality through the active
site. The two residues N-terminal to the trimethyllysine
residue (A24, R25 in the H1.4 peptide, A7, R8 in the
H3K9 peptide and G34, V35 in the H3K36 peptide)
adopt a similar conformation/orientation in all three
structures, with backbone hydrogen bonds between
KDM4A E169 and the peptide residues at the 1 and
2 positions (Fig. 3B/C). However, differences arise in
the conformations of the C-terminal regions of the
peptides. The H3K9me3 and H1.4K26me3 peptides
manifest similar conformations/orientations for the
three residues C-terminal to the target trimethyllysine
residue, sharing conserved interactions with KDM4A
K241, D135 and N86 (black dashes, Fig. 3B). By con-
trast with the H3K9men and H1.4K26me3 substrate
structures, the peptide backbone of H3K36 adopts a
more ‘bent’ conformation, likely enforced by the
Fig. 3. Binding mode of H1.4K26me3 to KDM4A. The figure shows views from (A) an X-ray crystal structure of KDM4A bound to nickel
(green, substitute for iron), NOG (pink, a 2OG mimetic inhibitor) and an H1.4(18–32)K26me3 peptide (yellow), alone, or overlaid with: (B) a
structure of KDM4A bound to H3(7–14)K9me3 peptide (cyan, PDB ID 2OQ6) [26], and (C) a structure of KDM4A bound to an H3K36me3
peptide (violet, PDB ID 2P5B) [47]. Residues from KDM4A in the H1.4K26 structure are shown as pale grey sticks, those from KDM4A in
the H3K9 structure are shown as pale green sticks and those from KDM4A in the H3K36 structure are shown as pale pink (A–C). Some of
the key interactions between KDM4A and the H1.4K26me3 peptide are shown by black dashes. Interactions between the H1.4K26me3
peptide and KDM4A conserved in the H3K9me3 peptide structure, but not in the H3K36me3 peptide structure are marked as pink dashes.
Interactions only observed in the H3K36me3 peptide structure are shown as green dashes. (D) Overlay of the peptide backbones (and
Kme3 side chain) of each peptide. The amide flip between the H3K36 peptide, and the H3K9 and H1.4K26 peptides, is highlighted with a
dashed black box.
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presence of a proline (H3P38) in its sequence. Thus, in
the K36 peptide, the backbone carbonyl of the H3K36
to K37 amide bond is ‘flipped’ ~180° compared to the
analogous amide in the other two substrates (Fig. 3D).
Unlike the H3K9 and H1.4K26 peptides (pink dashes,
Fig. 3C), the H3K36 peptide displays no interactions
with either KDM4A K241 or D135, nor with the side-
chain of N86. Instead, the backbone –NH of the
H3K36-K37 amide link interacts with the phenol of
Y175 (green dashes, Fig. 3C).
Overall, the crystallographic analyses reveal the
H1.4K26me3 substrate adopts a binding mode more
similar to that of H3K9me3 than H3K36me3. This
common binding geometry is supportive of their simi-
lar demethylation efficiencies.
Discussion
Though lysyl methylations have been reported on lin-
ker histones [10,45], the processes that both regulate
these methylation levels and contribute to their func-
tional roles are largely undefined. Demethylation of
methylated lysine residues at K26 of linker H1.4 has
been reported to be catalysed by the KDM4 subfamily
of JmjC KDMs in cells [15,43]. In previous studies on
H1.4, no activity was observed for the KDM3 or
KDM6 subfamilies; however, the KDM7 subfamily,
which, like the KDM4s, also act at H3K9 had not
been tested for activity with H1.4 [29,48,49]. Our
results demonstrate that at least in the context of his-
tone fragment peptides, recombinantly produced mem-
bers of both the human KDM4 and KDM7
subfamilies of JmjC KDMs are capable of catalysing
demethylation of methylated lysine residues at K26 of
linker H1.4. Demethylation of dimethylated H1.4K26
by KDM7A and KDM7B appears considerably less
efficient than the well-characterised H3K9me2 sub-
strates for these enzymes, possibly precluding any bio-
logical relevance [29,42,44]. However, kinetic analyses
with KDM4A reveal that demethylation of the
H1.4K26me3 peptide and the well-characterised
KDM4 H3K9me3 substrate are comparably efficient,
whereas the H3K36me3 substrate is less efficiently
demethylated than either H3K9me3 or H1.4K26me3
under the conditions tested [23,24,50,51].
Crystallographic analyses of H1.4K26me3 bound
to KDM4A imply very similar binding modes for
the H1.4K26me3 and an H3K9me3 peptides [26,47],
consistent with the kinetic studies which imply that
they are substrates of approximately equal efficiency.
Importantly, the H3K36me3 peptide, which at least
in vitro is a less efficient substrate for KDM4A-C
(and not a substrate at all for KDM4D/E) than
either H3K9me3 or H1.4K26me3, binds differently at
the KDM4A active site [23,47,50]. One clear differ-
ence is in the binding mode of the amide bond on
the C-terminal side of the N-methylated substrate
lysine for H3K9/H1.4K26 versus H3K36 (Fig. 3).
Although how this observation relates to the differ-
ent binding/catalytic efficiencies of the different pep-
tide sequences is difficult to dissect, it suggests that
subtle differences in binding conformation may have
substantial effects on catalytic efficiency, an observa-
tion relevant to functional assignment work on JmjC
KDMs [50,52]. Similar subtleties have been observed
for chromatin reader domains; in some cases they
bind similarly to the closely related H3K9 and
H1.4K26 sequences (e.g. HP1) [17], whilst in others
binding is only observed to one or the other (e.g.
ankyrin repeats of G9A) [43].
The combined biochemical and structural studies
thus identify methylated H1.4K26 peptides as sub-
strates for JmjC KDMs with broadly comparable
demethylation efficiencies to those reported for
KDM4 substrates on core histones [23,24,50,51].
Given this potential for activity at H1.4, it is of
interest to further investigate the consequence of
methylation at this position in vivo, in particular in
the context of ongoing medicinal chemistry studies
targeting the KDM4 subfamily as a treatment for
disease [7,53]. The methylation status of H1.4K26 is
reported to regulate binding of HP1 and other chro-
modomain proteins [16,17], which are associated with
formation of heterochromatin. Thus, the reversal of
this methylation by KDM4 enzymes in cells may
well have direct effects on chromatin compaction
and gene expression. It remains unclear whether a
complex and dynamic ‘histone code’ akin to that
proposed for the H3 N-terminal tail, exists for H1.
The dynamic modulation of PTMs would be a likely
requirement for this. Regulation of PTMs on H1.4
has already been demonstrated to play important
roles in gene regulation, as in the case of acetylation
of H1.4K34, which may help recruit the general
transcription factor IID through its bromodomain,
and which increases the dynamic exchange of H1
[54], or citrullination of H1.2R54, which results in
histone eviction and chromatin decondensation [55].
The ready demethylation of H1.4K26 as catalysed
by the KDM4 demethylase family argues that this
might also be the case for H1.4K26 methylation, at
least for H1.4K26me3 [12]. Overall, we hope that
our findings will stimulate further cellular work to
characterise the full scope of JmjC KDM substrate
selectivity and will be informative for ongoing stud-
ies with JmjC KDM inhibitors.
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